Silencing <i>cullin-1/5</i> decreased mRNA and protein expression of NF-κB dependent cytokines. by Attinder Chadha (11414273)

Subjects:

Arsenic trioxide cooperates with HSP90 or HDAC inhibitor to decrease mutant p53 expression and tumor cell proliferation. by Wensheng Yan (307121)

Ovariectomy decreases CA1 apical dendrite spine density in female apoE3 TR mice. by Rebecca C. Klein (551567)

Decreased eNOS activation and increased prepro-ET-1 expression in the lung tissue of MRL/lpr mice. by Koichi Sugimoto (582166)

LPC 18:1 lowers NO bioavailability and decreases eNOS dimer in EA.hy926 endothelial cells. by Andrijana Kozina (665147)

Decreased numbers of motor neurons in Tc1 and Dp(16)1Yey mice. by Sheona Watson-Scales (586942)

Mean TOC concentration and mean bacterioplankton abundance for Santa Barbara Channel phytoplankton-DOC experiments. by Anna K. James (3812875)

Deletion of <i>sagA</i> alone results in a decrease in nasopharyngeal infection. by Blake A. Shannon (14197601)

Coibamide A induces a time- and concentration-dependent decrease in plasma membrane integrity. by Andrew M. Hau (418935)

Decreased epithelial PGR expression in <i>Arid1a</i>^<i>d/d</i> mice. by Tae Hoon Kim (128536)

Sirt5 KO induces increased lysine succinylation and decreased ATP synthase activity in mouse heart mitochondria. by Mengli Zhang (6331172)

Decrease in CLPs, NKPS and Block in NKP progression. by John Richards (53768)

PI+ total immune cells are decreased at days 2, 5, and 14 following IR, and PI+ neutrophils are increased at day 30. by Jordan A. Gunning (18143970)

TIMP-4 overexpression decreases cell viability. by Floria Lizarraga (785275)

IL-18 increases expression of MLCK and pMLC via ROCK, and decreases that of phosphorylated STAT-5. by Ossama Allam (5043434)

Virus replication is decreased by treatment of HDAC inhibitors. by Angelika Danielsson (229695)

“…<p>LNCaP and PC-346C were transduced with Ad[i/PPT-E1A, E3] and Ad5 wt and BON cells were transduced with Ad[CgA-E1A] and Ad5 wt. …”

MES transiently decreases mitochondrial membrane potential. by Shingo Matsuyama (672132)

Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

“…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”

Reduced expression of Tks5 leads to decreased growth of tumor cells <i>in vitro</i> and <i>in vivo</i>. by Barbara Blouw (715467)

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)